Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-11

Clinical Trial Update: Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of pilocarpine ophthalmic spray for temporary improvement of near vision in presbyopic adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pilocarpine ophthalmic spray (pilocarpine)

Snippet

Sponsor: Eyenovia Inc. | Conditions: Presbyopia | Phase 3 | Status: COMPLETED